fashion -WSS

fashion

author：comprehensive 2025-09-06 03:57:48 - browse：87838

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Time to name cancers by genetics, not organ of origin, expert says

Wikipedia

WSS

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Removing probiotics from the NICU could threaten preemies' health

Diversify hospital leadership teams to protect BIPOC patient health

Removing probiotics from the NICU could threaten preemies' health

MoonLake credibility takes another hit with mid

The Sacklers, horror, and ‘The Fall of the House of Usher’

entertainment

fashion

focus

Medicare proposal to cover medical devices draws a mixed reaction

New Ultima Genomics DNA sequencer can read genome for $100

Medicare details structure of new drug price negotiation program

Time to name cancers by genetics, not organ of origin, expert says

In Memoriam: Notable people who died in 2023

UCSF medical school apologizes for unethical prisoner experiments

Malaria cases in Florida and Texas: Here’s what you need to know

Even great ERs can’t make up for American health disparities

Affirmative action in medical school literally saved lives

A clever new way to fix Medicaid and graduate medical education

knowledge

FDA approves Recor Medical high blood pressure device

More doctors should go into startup world

The real point of Kenneth Smith’s execution by nitrogen gas

What we need to know about Arena Bioworks

Study: New antibiotic targets gonorrhea as well as last existing drug

Commercial surrogacy can be ethical, despite pope’s claims

hotspot

entertainment

Wikipedia

focus